Non-gonococcal urogenital infection and drug resistance analysis.docVIP

  • 5
  • 0
  • 约6.01千字
  • 约 6页
  • 2017-05-04 发布于浙江
  • 举报

Non-gonococcal urogenital infection and drug resistance analysis.doc

Non-gonococcal urogenital infection and drug resistance analysis

 PAGE \* MERGEFORMAT 6 Non-gonococcal urogenital infection and drug resistance analysis Author: party Dongmei Liu Xiaobin, Yang Jianjun, Gao Yan, [Keywords:] Chlamydia trachomatis urethritis resistant Mycoplasma 0 Introduction Chlamydia trachomatis (chlamydozoa trachomatis, CT), Ureaplasma urealyticum (mycoplasma urealytium, MU) and Mycoplasma hominis (mycoplasma hominis, MH) urinary and reproductive tract infections caused by major pathogens, and the rate of infection there is a rising trend. As the treatment of incomplete, repeated infections, a large number of long-term application of antibiotics and the overuse of antibiotics, leading to drug resistance has also been increased to bring about a considerable difficulty in clinical treatment. In order to understand the region of non-gonococcal urethritis (NGU), cervicitis, prostatitis of mycoplasma infection and drug resistance testing and drug resistance analysis of Mycoplasma. An object and method 1.1 Object source and specimen collection 2005  01/2006  03 come to my hospital out-patient clinic patients, both sexual history. Specimens collected were not used antibiotics before sampling. Female patients to take cervical, vaginal secretions, male patients taking the urethra secretions, prostatic fluid. specimens processed immediately at room temperature (18 ~ 25 ℃ ) placed under no more than 4 h, 4 ℃ to save no more than 48 h. Mycoplasma IST and drug sensitivity kit purchased in France, bioMerieux company. Chlamydia Clearview kit purchased the company in the United Kingdom. 1.2 method of specimen collection, treatment at 37 ℃ constant temperature incubator, incubated for 48 h observation, there are positive for bacterial growth, no bacterial growth was negative. Detection, susceptibility testing and the results to determine the validity of instructions carried out in strict accordance with kit . 2 Results 2.1 Chlamydia and Mycoplasma infection infection in Table 1. Table 1CT, MU, MU + MH and MH

文档评论(0)

1亿VIP精品文档

相关文档